Health AI Central
Share:
Peer-Reviewed Publication
Diabetes Obes Metab2026August 10, 2026Journal Article

AI Patient Support and 6-Month Medication Adherence in a Digital Obesity Program: A Retrospective Analysis.

Louis Talay1, Connie Xu2, John Alderete2, Jason Hom3, Marilyn Tan3, Neera Ahuja3
1Eucalyptus Health, Sydney, New South Wales, Australia.
2Amigo AI, New York, New York, USA.
3Department of Medicine, Stanford University Medical Centre, Stanford, California, USA.
PubMed DOI

Abstract

BACKGROUND: Real-world glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapies face substantial attrition rates in commercial digital weight loss services (DWLSs). Conversational artificial intelligence (AI) has been proposed to enhance patient support at production scale, but robust evidence of its effectiveness in improving medication retention is scarce. OBJECTIVES: To evaluate the effec…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.